• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Application of Resazurin and ATP Detection Cell Viability Assays for Drug Sensitivity Screening in Ewing Sarcoma
 
  • Details
  • Full
Options
2027
Book Article
Title

Application of Resazurin and ATP Detection Cell Viability Assays for Drug Sensitivity Screening in Ewing Sarcoma

Abstract
Developing new effective therapies for Ewing sarcoma (EwS) is crucial to improving patient outcomes, especially in cases of metastatic or recurrent disease. In various stages of drug discovery and especially early preclinical development, cell viability assays are often used to assess the antitumor efficacy of compounds of interest. Here, we review and provide guidelines for the application of resazurin- and ATP-based cell viability assays for drug sensitivity screening in EwS. This includes dose-response drug screening to identify metrics such as potency and to compare sensitivity across multiple cell lines, as well as high-throughput drug screening to identify hit compounds that inhibit EwS cells.
Author(s)
Jeschke, Annika
German Cancer Research Center
Musa, Julian
German Cancer Research Center
Cidre-Aranaz, Florencia
German Cancer Research Center
Ohmura, Shunya
German Cancer Research Center
Gul, Sheraz
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Mainwork
Ewing Sarcoma  
DOI
10.1007/978-1-0716-5587-0_12
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Keyword(s)
  • Cell viability

  • Drug screening

  • Ewing sarcoma

  • Fluorescence

  • Luminescence

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024